9th Annual Biomarkers Congress

Antibodies: Biogen Idec

Total Score People Score Events Score
10 9 9
Date Event Presentation Speakers
November 29, 2011 The 7th annual European Antibody Congress is the worldleading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development. STREAM 1 | Chairman Alexey Lugovskoy
Systems biology approach to the design of optimal antibody-like therapeutic molecules Alexey Lugovskoy
January 13, 2011 Inaugural Antibody Drug Products Advances in the Pre-Clinical Development of IgG-Like Bispecific Antibodies Scott M Glaser
January 10, 2011 Third Annual Optimizing Biologics Formulation Development Optimizing Processing Conditions to Avoid Process Stress Induced Aggregation Carl Charlie Hitscherich
May 19, 2010 Pre-Clinical / Clinical Development of Therapeutic Antibodies Surrogates: Their Use, Qualification and Challenges Janet Clarke
May 17, 2010 Immunogenicity of Therapeutic Biologics Development of Point-of-Care Assay for Detection of Anti-Drug Antibodies  Tatiana Plavina
May 4, 2010 Biomarker World Congress 2010 Impact of Biomarkers on Clinical Development Shabnam Tangri
August 3, 2009 The Next Wave of Antibody Therapeutics An Antibody-Cytotoxic Conjugate, BIIB015, is a New Targeted Therapy for Cripto Positive Tumors Michele Sanicola-Nadel
May 1, 2008 Monoclonal Antibodies Rational Optimization of Therapeutic Bispecifi c and Tetravalent Antibodies Alexey Lugovskoy
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Stability Indicating Methods and Interpretation of Stability Data for Biotech Products (09:15-12:15) Matthias Kretschmer
Stability Indicating Methods and Interpretation of Stability Data for Biotech Products: Interpretation of Stability Data (11:45-12:15) Matthias Kretschmer
Impact of Extractables and Leachables on Well CExtharacterized Protein Products: Extractables and Leachables Panel Discussion - Perspectives from the Suppliers,Topics to be discussed include: (11:30-12:10) Richard Strong
Impact of Extractables and Leachables on Well Characterized Protein Products (10:45-13:25) Richard Strong
Impact of Extractables and Leachables on Well Characterized Protein Products: Extractable and Leachable Issues and Concerns for Biopharmaceuticals - A Manufacturer's Perspective (11:15-11:30) Richard Strong
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.